SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/ A4/ C3/ A1 locus on chromosome 11q23 in the Northern Irish population
Serum triglyceride levels (TG) are important independent risk factors for coronary heart disease. The apolipoproteins C-III (apoCIII) and A-V (apoAV) are central to normal TG metabolism and the complete sequence analysis of these genes was carried out in severe cases (TG > 9 mmol/l) and controls...
Gespeichert in:
Veröffentlicht in: | Atherosclerosis 2006-04, Vol.185 (2), p.353-360 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Serum triglyceride levels (TG) are important independent risk factors for coronary heart disease. The apolipoproteins C-III (apoCIII) and A-V (apoAV) are central to normal TG metabolism and the complete sequence analysis of these genes was carried out in severe cases (TG
>
9
mmol/l) and controls (TG
<
2
mmol/l). A total of 53 SNPs were identified in these genes with 17 being novel to this study. Further analysis defined four
APOC3 SNPs and three
APOA5 SNPs showing strong association with TG levels. Analysis of the two major SNPs from
APOA5 [c.56C
>
G, c.-3A
>
G] and from
APOC3 [c.102C
>
T, c.340C
>
G] using THESIAS has identified two major haplotypes relative to the most common CACC haplotype showing very strong association with hypertriglyceridaemia, CGTG and GATC (odds ratio 7.45 and 5.26). Logistic regression analysis of these four SNPs revealed that, carriage of the
APOA5 c.56 G allele (odd ratios 4.49) and the
APOA5 c.-3 G allele (odds ratio 3.23) were strong independent predictors of hypertriglyceridaemia (
P
<
0.001), whereas in contrast, carriage of the
APOC3 c102 T allele (odds ratio 1.35) and the
APOC3 c.340 G allele (odds ratio 1.37), did not show any significant effects that were independent of
APOA5. |
---|---|
ISSN: | 0021-9150 1879-1484 |
DOI: | 10.1016/j.atherosclerosis.2005.06.043 |